288 related articles for article (PubMed ID: 22069706)
1. Imaging of convection enhanced delivery of toxins in humans.
Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
[TBL] [Abstract][Full Text] [Related]
2. Convection enhanced delivery of macromolecules for brain tumors.
Mehta AI; Choi BD; Ajay D; Raghavan R; Brady M; Friedman AH; Pastan I; Bigner DD; Sampson JH
Curr Drug Discov Technol; 2012 Dec; 9(4):305-10. PubMed ID: 22339074
[TBL] [Abstract][Full Text] [Related]
3. Convection-enhanced delivery in clinical trials.
Hall WA; Rustamzadeh E; Asher AL
Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
[TBL] [Abstract][Full Text] [Related]
4. Convection-enhanced drug delivery for glioblastoma: a review.
D'Amico RS; Aghi MK; Vogelbaum MA; Bruce JN
J Neurooncol; 2021 Feb; 151(3):415-427. PubMed ID: 33611708
[TBL] [Abstract][Full Text] [Related]
5. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
[TBL] [Abstract][Full Text] [Related]
6. Novel delivery strategies for glioblastoma.
Zhou J; Atsina KB; Himes BT; Strohbehn GW; Saltzman WM
Cancer J; 2012; 18(1):89-99. PubMed ID: 22290262
[TBL] [Abstract][Full Text] [Related]
7. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
[TBL] [Abstract][Full Text] [Related]
8. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.
Jahangiri A; Chin AT; Flanigan PM; Chen R; Bankiewicz K; Aghi MK
J Neurosurg; 2017 Jan; 126(1):191-200. PubMed ID: 27035164
[TBL] [Abstract][Full Text] [Related]
9. Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.
Ung TH; Malone H; Canoll P; Bruce JN
CNS Oncol; 2015; 4(4):225-34. PubMed ID: 26103989
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.
Saito R; Krauze MT; Bringas JR; Noble C; McKnight TR; Jackson P; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Hong K; Berger MS; Park JW; Bankiewicz KS
Exp Neurol; 2005 Dec; 196(2):381-9. PubMed ID: 16197944
[TBL] [Abstract][Full Text] [Related]
11. Convection-enhanced delivery for the treatment of glioblastoma.
Vogelbaum MA; Aghi MK
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii3-ii8. PubMed ID: 25746090
[TBL] [Abstract][Full Text] [Related]
12. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
[TBL] [Abstract][Full Text] [Related]
13. Convection and retro-convection enhanced delivery: some theoretical considerations related to drug targeting.
Motion JP; Huynh GH; Szoka FC; Siegel RA
Pharm Res; 2011 Mar; 28(3):472-9. PubMed ID: 20963628
[TBL] [Abstract][Full Text] [Related]
14. The use of convection-enhanced delivery with liposomal toxins in neurooncology.
Fiandaca MS; Berger MS; Bankiewicz KS
Toxins (Basel); 2011 Apr; 3(4):369-97. PubMed ID: 22069714
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.
Debinski W; Tatter SB
Curr Opin Mol Ther; 2010 Dec; 12(6):647-53. PubMed ID: 21154156
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive outlook on intracerebral therapy of malignant gliomas.
Buonerba C; Di Lorenzo G; Marinelli A; Federico P; Palmieri G; Imbimbo M; Conti P; Peluso G; De Placido S; Sampson JH
Crit Rev Oncol Hematol; 2011 Oct; 80(1):54-68. PubMed ID: 20888252
[TBL] [Abstract][Full Text] [Related]
17. Liposomal temozolomide drug delivery using convection enhanced delivery.
Nordling-David MM; Yaffe R; Guez D; Meirow H; Last D; Grad E; Salomon S; Sharabi S; Levi-Kalisman Y; Golomb G; Mardor Y
J Control Release; 2017 Sep; 261():138-146. PubMed ID: 28666727
[TBL] [Abstract][Full Text] [Related]
18. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1.
Ding D; Kanaly CW; Bigner DD; Cummings TJ; Herndon JE; Pastan I; Raghavan R; Sampson JH
J Neurooncol; 2010 May; 98(1):1-7. PubMed ID: 19898744
[TBL] [Abstract][Full Text] [Related]
20. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
Ferguson S; Lesniak MS
Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
